Battle of the scopes: which technique best wipes out Barrett's lesions?

NCT ID NCT05276791

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This trial compares two endoscopic procedures—endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD)—for removing visible precancerous lesions in people with Barrett's esophagus. About 331 adults with Barrett's esophagus and early-stage abnormal tissue will be randomly assigned to one of the two techniques. The goal is to see which method more completely removes the lesions and prevents them from coming back within a year, without using ablation therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD)
What this could lead to
If one technique proves superior, it could become the standard approach for removing early-stage lesions in Barrett's esophagus, reducing the risk of cancer progression.
What could go wrong
This is a single trial with 331 participants, and results may not apply to all patients. ESD is more complex and carries a higher risk of complications like bleeding or perforation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARRETT ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Amsterdam University Medical Center

    RECRUITING

    Amsterdam, Netherlands

  • Catharina Ziekenhuis

    RECRUITING

    Eindhoven, Netherlands

  • Erasmus Medical Center

    RECRUITING

    Rotterdam, Netherlands

  • St. Antonius Ziekenhuis

    RECRUITING

    Nieuwegein, Netherlands

  • University Medical Center Groningen

    RECRUITING

    Groningen, Netherlands

  • University Medical Center Utrecht

    RECRUITING

    Utrecht, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.